Cargando…

Utility of Soluble CD163 in the Clinical Management of Patients With Kawasaki Disease

Objective: Intravenous immunoglobulin (IVIG) therapy is a useful first-line treatment for Kawasaki disease (KD); however, 10–20% of patients fail to respond and require additional IVIG. Soluble CD163 (sCD163) is considered a biomarker for macrophage activation. There are no reports measuring serum s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azuma, Yoshihiro, Suzuki, Yasuo, Okada, Seigo, Matsuguma, Chie, Wakiguchi, Hiroyuki, Ohnishi, Yuji, Furuta, Takashi, Miyake, Akiko, Yasudo, Hiroki, Ichihara, Kiyoshi, Ohga, Shouichi, Hasegawa, Shunji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154120/ https://www.ncbi.nlm.nih.gov/pubmed/32318530 http://dx.doi.org/10.3389/fped.2020.00148

Ejemplares similares

Two infants with tuberculid associated with Kawasaki disease
por: Yamada, Hiroko, et al.
Publicado: (2016)

Time-Course Evaluation of Body Mass Index in Japanese Children With Obstructive Sleep Apnea Syndrome After Adenotonsillectomy: A Three-Years Follow-Up Study
por: Fukuda, Ken, et al.
Publicado: (2020)

Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and -18 levels
por: Wakiguchi, Hiroyuki, et al.
Publicado: (2015)

A Sporadic Neonatal Case of Epidermolysis Bullosa Simplex Generalized Intermediate with KRT5 and KRT14 Gene Mutations
por: Wakiguchi, Hiroyuki, et al.
Publicado: (2016)

Multiple heart beats: A unique presentation of cardiac rhabdomyoma
por: Okada, Seigo, et al.
Publicado: (2021)

Kawasaki Disease Following Severe Sunburn Injury
por: Okada, Seigo, et al.
Publicado: (2020)

A novel mutation in early‐onset sarcoidosis/Blau syndrome: an association with Propionibacterium acnes
por: Okazaki, Fumiko, et al.
Publicado: (2021)

Diagnostic Utility of Ultrasonography for Duodenal Ulcers in Pediatric Cases in Japan
por: Sakata, Yasufumi, et al.
Publicado: (2020)

Food Protein-Induced Enterocolitis Syndrome in Children with Down Syndrome: A Pilot Case-Control Study
por: Okazaki, Fumiko, et al.
Publicado: (2022)

Erythema Nodosum Masking Kawasaki Disease with an Initial Manifestation of Skin Lesions
por: Okada, Seigo, et al.
Publicado: (2019)

Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’ in plasma
por: Etzerodt, Anders, et al.
Publicado: (2017)

Pulmonary inflammation and cytokine dynamics of bronchoalveolar lavage fluid from a mouse model of bronchial asthma during A(H1N1)pdm09 influenza infection
por: Fujimoto, Yousuke, et al.
Publicado: (2017)

Enhanced airway hyperresponsiveness in asthmatic children and mice with A(H1N1)pdm09 infection
por: Ariyoshi, Taira, et al.
Publicado: (2021)

Soluble CD 163: A novel biomarker
por: Ahuja, Rajeev B.
Publicado: (2011)

Local production of soluble CD163 in the spondyloarthropathic joint
por: Baeten, D, et al.
Publicado: (2003)

Soluble CD163 as a Potential Biomarker in Systemic Sclerosis
por: Frantz, Camelia, et al.
Publicado: (2018)

Soluble CD163 in intracerebral hemorrhage: biomarker for perihematomal edema
por: Roy‐O'Reilly, Meaghan, et al.
Publicado: (2017)

Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study
por: Feng, Lin, et al.
Publicado: (2012)

Soluble CD163 and CD163 Expression on Monocytes Associated with Chronic Hepatitis B Inflammation and HBsAg Loss
por: Xie, Peilin, et al.
Publicado: (2022)

Subarachnoid hemorrhage due to nonbranching aneurysm of the middle cerebral artery in a young adult with a history of Kawasaki disease
por: Ishida, Atsushi, et al.
Publicado: (2014)

Soluble CD163-Associated Dietary Patterns and the Risk of Metabolic Syndrome
por: Hu, Tzu-Yu, et al.
Publicado: (2019)

Soluble CD163 Is a Predictor of Mortality in Patients With Decompensated Cirrhosis
por: Zhang, Yue, et al.
Publicado: (2021)

Kawasaki Disease and Vaccination: Prospective Case-Control and Case-Crossover Studies among Infants in Japan
por: Murata, Kenji, et al.
Publicado: (2021)

Blood Reference Intervals for Preterm Low-Birth-Weight Infants: A Multicenter Cohort Study in Japan
por: Ochiai, Masayuki, et al.
Publicado: (2016)

Pretreatment Lymphocyte to Monocyte Ratio as a Prognostic Marker for Advanced Pulmonary Squamous Cell Carcinoma Treated With Chemotherapy
por: Minami, Seigo, et al.
Publicado: (2018)

Pretreatment Lung Immune Prognostic Index Is a Prognostic Marker of Chemotherapy and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
por: Minami, Seigo, et al.
Publicado: (2019)

Gustave Roussy Immune Score Is a Prognostic Factor for Chemotherapy-Naive Pulmonary Adenocarcinoma With Wild-Type Epidermal Growth Factor Receptor
por: Minami, Seigo, et al.
Publicado: (2019)

Gustave Roussy Immune Score and Royal Marsden Hospital Prognostic Score Are Prognostic Markers for Extensive Disease of Small Cell Lung Cancer
por: Minami, Seigo, et al.
Publicado: (2020)

Systemic Epstein–Barr Virus-Positive T/NK Lymphoproliferative Diseases With SH2D1A/XIAP Hypomorphic Gene Variants
por: Ishimura, Masataka, et al.
Publicado: (2019)

Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2021)

Soluble CD163 Identifies Those at Risk for Increased Hepatic Inflammation & Fibrosis
por: Sherman, Kenneth E, et al.
Publicado: (2021)

CD163 deficiency facilitates lipopolysaccharide‐induced inflammatory responses and endotoxin shock in mice
por: Fujiwara, Yukio, et al.
Publicado: (2020)

Soluble CD163: A novel biomarker for the susceptibility to sepsis in severe burn injuries
por: Piatkowski, Andrzej, et al.
Publicado: (2011)

Soluble haemoglobin scavenger receptor (sCD163): a marker associated with bacteraemia
por: Gaïni, S, et al.
Publicado: (2005)

Soluble CD163 and TWEAK in early pregnancy gestational diabetes and later glucose intolerance
por: Dereke, Jonatan, et al.
Publicado: (2019)

Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
por: Vajavaara, Heli, et al.
Publicado: (2021)

Urinary Soluble CD163 Levels Predict IgA Nephropathy Remission Status
por: Gong, Shaomin, et al.
Publicado: (2021)

Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease
por: Nissen, Sara Konstantin, et al.
Publicado: (2020)

Urine Soluble CD163 Is a Promising Biomarker for the Diagnosis and Evaluation of Lupus Nephritis
por: Huang, Yun-Ju, et al.
Publicado: (2022)

Soluble CD163 is a predictor of fibrosis and hepatocellular carcinoma development in nonalcoholic steatohepatitis
por: Kawanaka, Miwa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ovmemd4oqdi0u021f1rookl1fu